(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CI-CA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CI-CA

ST13

US500000079065171

Class

5, 10

Filing

79065171

Registration

3658394

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

04/15/2024

Trademark type

Word

Nice classes

5, 10

Filing date

01/05/2009

Registration date

07/21/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/26/2016

Last transaction

11/18/2018

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

DE

Examiner

LOWRY, LEIGH A

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Fresenius Medical Care Deutschland GmbH

Representatives

Fresenius SE, Trademark Department

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for extracorporeal blood purification

Class 10

Surgical and medical instruments and apparatus for extracorporeal blood purification

Publications

History of USPTO decisions and trademark events.

23 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/15/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/06/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/26/2019

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

02/23/2018

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

10/20/2017

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

04/28/2017

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

02/16/2017

XXCR

GENERIC MADRID TRANSACTION CREATED

02/15/2017

RFNT

REFUSAL PROCESSED BY IB

12/23/2016

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

10/26/2016

RFNT

REFUSAL PROCESSED BY IB

07/15/2016

C71T

CANCELLED SECTION 71

02/26/2016

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

04/01/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

07/21/2009

PUBO

PUBLISHED FOR OPPOSITION

05/05/2009

NPUB

NOTICE OF PUBLICATION

04/15/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/28/2009

ALIE

ASSIGNED TO LIE

03/28/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/28/2009

DOCK

ASSIGNED TO EXAMINER

03/20/2009

MAFR

APPLICATION FILING RECEIPT MAILED

03/10/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/06/2009

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/05/2009

Continuous trademark protection

Get notified about every new filing that threatens CI-CA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.